Pfizer CEO begins contributing to LinkedIn's publishing platform

Pfizer CEO Ian Read

Pfizer ($PFE) CEO Ian Read has become the first pharma executive to contribute an article to LinkedIn's ($LNKD) publishing platform. LinkedIn invited Bill Gates, Richard Branson and other business leaders to contribute posts to the platform in 2012, but no pharma executives were included at that time. Now, Read has begun contributing to the site. The Pfizer CEO's first post discusses the importance of reputation to pharma companies. "Making reputation and respect all the more important to us is knowing that we gain it in drops, but lose it in gallons," Read wrote. Blog | More